Elizabeth Pingpank Hickin leads investor relations and corporate communications at Tango. Prior to Tango, Liz held roles of increasing responsibility at Takeda Oncology, bluebird bio, 2seventy bio and Zentalis Pharmaceuticals. At Takeda Oncology, Liz lead product communications for Adcetris, Ninlaro and Velcade. She joined bluebird in 2016, leading investor communications around key data readouts, regulatory milestones and product launches. She joined 2seventy bio upon its spin from bluebird, leading investor relations through the launch of Abecma. She was most recently head of investor relations at Zentalis Pharmaceuticals in San Diego.

Liz holds a Bachelor of Arts degree from Georgetown University.